Inventor · Laguna Beach, CA, US

Ken Chow

125Patents
10h-index
30Co-inventors
80Inventor score

Filing activity: Dec 13, 1989 → Mar 1, 2017

Most-cited inventions

PatentTitleAreaCited byStatus
US7091232B2 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds Chemistry; Metallurgy 72 Expired
US6329369A Methods of treating pain and other conditions Chemistry; Metallurgy 47 Expired
US7141597B2 Nonsedating α-2 agonists Chemistry; Metallurgy 46 Expired
US6534542B2 (2-hydroxy)ethyl-thioureas useful as modulators of &agr;2B adrenergic receptors Chemistry; Metallurgy 43 Expired
US6545182B2 Methods and compositions for modulating alpha adrenergic receptor activity Chemistry; Metallurgy 42 Expired
US6841684B2 Imidiazoles having reduced side effects Chemistry; Metallurgy 37 Expired
US7276522B2 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds Chemistry; Metallurgy 31 Expired
US7335803B2 Methods and compositions for modulating alpha adrenergic receptor activity Human Necessities 25 Expired
US6313172A Methods and compositions for modulating alpha adrenergic receptor activity Chemistry; Metallurgy 17 Expired
US5300499A 5-substituted 3-thiophene sulfonamides as antiglaucoma agents Chemistry; Metallurgy 14 Expired
US5519040A Substituted thiazole sulfonamides as antiglaucoma agents Chemistry; Metallurgy 9 Expired
US7323477B2 7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline Human Necessities 9 Expired
US7902247B2 Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors Chemistry; Metallurgy 9 Active
US8329918B2 Selective alpha 2B/2C agonists Chemistry; Metallurgy 7 Active
US8987471B2 Substituted dihydropyrazoles as sphingosine receptor modulators Chemistry; Metallurgy 6 Active
US8735438B2 Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors Chemistry; Metallurgy 5 Active
US7399868B2 4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists Chemistry; Metallurgy 4 Expired
US8063087B2 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds Chemistry; Metallurgy 4 Active
US8273776B2 Biphenyl oxadiazole derivatives as sphingosine-1-phosphate receptors modulators Human Necessities 4 Active
US7323485B2 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds Chemistry; Metallurgy 4 Active
US7345077B2 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds Chemistry; Metallurgy 4 Expired
US8492422B2 Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions Chemistry; Metallurgy 3 Active
US7419994B2 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds Chemistry; Metallurgy 3 Active
US7358269B2 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one Chemistry; Metallurgy 3 Active
US8653123B2 Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases Chemistry; Metallurgy 3 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.